Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Herbalife

This article was originally published in The Tan Sheet

Executive Summary

Marketing, distribution and administrative expenses decline 9% due to reductions in distribution and overhead for Q1 compared to prior-year period, Los Angeles-based direct marketer reports in analysts call April 26. U.S. retail sales fall almost 11% to $109.8 mil. Worldwide net sales also down 13% to $399.7 mil., which Herbalife attributes to volume declines in the Asia/Pacific Rim region and foreign currency fluctuations. Net income reached $8.6 mil., up 46% from 2000 first quarter, when the company took a one-time, pre-tax charge of $9.5 mil

You may also be interested in...



Herbalife Management Conflicts Of Interest Questioned By Investment Groups

Herbalife execs' dual responsibilities as directors of the firm and trustees in the estate of its founder could produce "serious conflicts of interest," two investment groups charge in a July 24 letter to the board.

Herbalife Management Conflicts Of Interest Questioned By Investment Groups

Herbalife execs' dual responsibilities as directors of the firm and trustees in the estate of its founder could produce "serious conflicts of interest," two investment groups charge in a July 24 letter to the board.

Herbalife Management Conflicts Of Interest Questioned By Investment Groups

Herbalife execs' dual responsibilities as directors of the firm and trustees in the estate of its founder could produce "serious conflicts of interest," two investment groups charge in a July 24 letter to the board.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS092485

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel